|

Seattle’s Pacific Health Summit, the “Davos” of Global Health, Zeroes in on Tuberculosis (United States)
Xconomy Seattle, www.xconomy.com, June 16, 2009, by Luke Timmerman, ltimmerman@xconomy.com
TB is the main theme of discussion at the Pacific Health Summit in Seattle, Washington. The invitation-only annual conference of about 250 world leaders in science, politics, and business will include Margaret Chan, director-general of the World Health Organization; Chris Viehbacher, CEO of the drug and vaccine pharmaceutical company Sanofi-Aventis; Anthony Fauci, Director, US National Institute of Allergy and Infectious Diseases; and Paul Farmer, founding director of Partners in Health. Other pharmaceutical companies invited include Merck, GlaxoSmithKline, Johnson and Johnson, and Bayer.
South Africa Leads Hunt for Killer TB Vaccine
Reuters, June 5, 2009, by Wendell Roelf
Researchers in South Africa next month will begin trials evaluating a vaccine for TB, a disease estimated to affect one in three people globally. “The world needs a new TB vaccine because the current one is not really effective in terms of preventing TB and that is manifest in the context of an increasing epidemic,” said Gregory Hussey, director of the South African TB Vaccine Initiative. The most promising vaccine of nine candidates, MVA85A, will be tested among 2,874 children under the age of one. The goal is to register a new TB vaccine by 2015. Read more [+/-]
|

|